Immix Biopharma, Inc. Common Stock (IMMX) is a publicly traded Healthcare sector company. As of May 21, 2026, IMMX trades at $9.87 with a market cap of $489.16M and a P/E ratio of -9.91. IMMX moved +1.02% today. Year to date, IMMX is +75.29%; over the trailing twelve months it is +323.70%. Its 52-week range spans $1.26 to $11.61. Analyst consensus is strong buy with an average price target of $18.25. Rallies surfaces IMMX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Immix Biopharma, Inc. Common Stock (IMMX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IMMX moved +1.02% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $9.87 |
| Market Cap | $489.16M |
| P/E Ratio | -9.91 |
| EPS | $-0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.61 |
| 52-Week Low | $1.26 |
| Volume | 33.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-29.44M |
| Gross Margin | 0.00% |
4 analysts cover IMMX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $18.25.